Responses
Other responses
Jump to comment:
- Published on: 23 November 2015
- Published on: 23 November 2015
- Published on: 23 November 2015Pyridostigmine in CHF: Author's Response to Dr. NobregaShow More
Dear Editor
We greatly appreciate Dr Nobrega’s interest in our recent publication on the acute effects of pyridostigmine on post-exercise heart rate recovery in patients with chronic heart failure.[1]
In accord with our published submaximal exercise data at anaerobic threshold, our more complete analysis of submaximal exercise demonstrated no differences between the effects of pyridostigmine 30 mg and pl...
Conflict of Interest:
None declared. - Published on: 23 November 2015Cholinergic stimulation in chronic heart failure: modifiyng predictors of riskShow More
Dear Editor
The article by Androne et al.[1] describing the improvement in heart rate recovery after maximal exercise in patients with chronic heart failure when treated with pyridostigmine, supports the recent concept that cholinergic stimulation may have a protective role in cardiovascular disease.[2] We have prompted to investigate this possibility, since depressed heart rate variability[3] and baroref...
Conflict of Interest:
None declared.